美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=MIRABEGRON"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
MIRABEGRON 209413 001 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 50MG No No 2018/10/12 (TA) -- AUROBINDO PHARMA LTD None (Tentative Approval)
MIRABEGRON 209446 001 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 25MG No No 2019/12/27 2019/12/27 SAWAI USA Discontinued
MIRABEGRON 209485 001 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 25MG No No 2022/09/28 2022/09/28 LUPIN LTD Prescription
MIRABEGRON 209485 002 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 50MG No No 2022/09/28 2022/09/28 LUPIN LTD Prescription
MIRABEGRON 209488 001 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 25MG No No 2022/09/29 2022/09/29 ZYDUS PHARMS Prescription
MIRABEGRON 209488 002 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 50MG No No 2022/09/29 2022/09/29 ZYDUS PHARMS Prescription
MIRABEGRON 215948 001 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 25MG No No 2024/02/12 2024/02/12 ALKEM LABS LTD Prescription
MIRABEGRON 215948 002 ANDA MIRABEGRON TABLET, EXTENDED RELEASE;ORAL 50MG No No 2024/02/12 2024/02/12 ALKEM LABS LTD Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database